A low-budget thriller shot in Croatia has become an unlikely waypoint in one of Hollywood's more closely watched comebacks.
The deal
Quiver Distribution has acquired worldwide rights to Citizen Vigilante, the action thriller directed by Uwe Boll and starring Armie Hammer, Variety reported. The deal covers most major territories, and follows the film's North American digital release earlier in June. Hammer plays a former U.S. Army officer who wages a one-man campaign against criminals and corrupt officials in an unnamed European city; Costas Mandylor co-stars as the investigator pursuing him.
A film built for controversy
The project arrived with built-in friction. German regulators declined to give the film an age rating — effectively keeping it out of theaters there — citing concerns about its violent content, and Boll has long courted exactly this kind of attention. The billionaire Elon Musk amplified it further by posting the full film to his X account for a window in late June, exposing it to his hundreds of millions of followers. Reviews have been mixed to harsh; the attention, by the standards of a roughly $2 million production, has been outsized.
Hammer's road back
For Hammer, the distribution news is as much a career story as a business one. The Call Me by Your Name and The Man from U.N.C.L.E. actor was dropped by his agency and stepped away from Hollywood in early 2021 after allegations surfaced against him. The Los Angeles Police Department investigated, and in May 2023 the Los Angeles County District Attorney's office declined to file charges, citing insufficient evidence; Hammer has denied the allegations. In interviews about his return, he has described the depth of his professional exile and his eagerness to work again.
A test case
With prosecutors having closed their inquiry and Citizen Vigilante now headed for global release, Hammer has re-entered the public conversation — not through a studio rehabilitation campaign but via a low-budget European production that found attention precisely by operating outside the Hollywood mainstream. Boll has floated a sequel; Hammer's involvement is unconfirmed. Whether the film proves a genuine relaunch or a passing curiosity, its worldwide deal shows that some corners of the international market are willing to bet on the name above the title.



